Paloma Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-24,992
Closed -$50K 2302
2020
Q2
$50K Buy
+24,992
New +$49K ﹤0.01% 1992
2019
Q4
Sell
-42,800
Closed -$129K 2361
2019
Q3
$129K Buy
+42,800
New +$133K ﹤0.01% 1815
2019
Q2
Sell
-15,903
Closed -$88K 2009
2019
Q1
$88K Buy
15,903
+4,903
+45% +$29.8K ﹤0.01% 1606
2018
Q4
$73K Buy
+11,000
New +$89.1K ﹤0.01% 1137
2017
Q4
Sell
-69,521
Closed -$854K 2146
2017
Q3
$854K Buy
69,521
+9,307
+15% +$137K 0.03% 1236
2017
Q2
$991K Sell
60,214
-10,458
-15% -$162K 0.03% 1202
2017
Q1
$1.01M Buy
70,672
+12,967
+22% +$192K 0.03% 1236
2016
Q4
$798K Buy
+57,705
New +$926K 0.02% 1284
2014
Q3
Sell
-2,611
Closed -$29K 1197
2014
Q2
$29K Buy
+2,611
New +$28K ﹤0.01% 1069

Other funds holding LXRX